Lawsuits Against Xarelto Reach 18,600

Thousands of people have brought lawsuits against the blood-thinning drug Xarelto, claiming it caused uncontrolled bleeding.

These lawsuits against Xarelto are now being heard in a series of bellwether trials related to the drug.

Recently, the Louisiana Record reported as many as 18,600 suits have been filed against the drug companies Johnson & Johnson and Bayer AG.

However, the drug companies were cleared in two bellwether trials in lawsuits against Xarelto.

lawsuits against Xarelto mount

lawsuits against Xarelto mount

Johnson & Johnson and Bayer AG were found to be not responsible for the death of a 67-year-old woman whose family blamed the blood-thinning drug, reported Bloomberg.

The verdict represented the second win for the drug companies which jointly developed the drug. Xarelto is linked to at least 370 deaths, according to U.S. Food and Drug Administration reports.

The plaintiffs claim Xarelto causes unstoppable bleeding in some cases and Bayer and J&J failed to provide an antidote or to warn doctors or consumers of a blood test that could monitor a patient’s bleed-out risk.

Xarelto is big business, according to Bloomberg. The drug is Bayer’s top-selling product. It generated $3.24 billion in sales last year and $2.5 billion in 2015 for the German pharmaceutical company. The blood thinner is J&J’s third-largest seller, making it $2.29 billion in 2016.

Lawsuits Against Xarelto Mount in the United States

Our Virginia dangerous drugs attorneys noted how lawsuits brought over this drug mounted over the last three years.

We are concerned about the fact Xarelto is linked to hundreds of deaths and thousands of complications. The lack of an antidote to stop bleed outs is extremely worrying.

Lawyers for J&J said the two jury verdicts reflect the appropriateness of the labeling of Xarelto’s (rivaroxaban) FDA-approved labeling.

Xarelto was approved by the U.S. Food and Drug Administration six years ago. The drug is widely prescribed for people suffering from heart problems like atrial fibrillation. The drug is also prescribed to cut the risk of deep vein thrombosis and pulmonary embolisms in patients.

The plaintiffs claim both Johnson & Johnson nor Bayer failed to make users and doctors aware of the serious potential side-effects of uncontrollable and irreversible bleeding linked to Xarelto’s use.

You can read more about Xarelto and its possible side-effects here on our website. If you have been hurt by this drug or a family member has lost their life, please call us at (757) 455-0077.

Mike Snellings

Post a Comment

Your email is never published nor shared. Required fields are marked *